Home/Filings/4/0001566044-18-000012
4//SEC Filing

Kwon Paul 4

Accession 0001566044-18-000012

CIK 0001566044other

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 6:43 PM ET

Size

5.3 KB

Accession

0001566044-18-000012

Insider Transaction Report

Form 4
Period: 2018-12-10
Kwon Paul
Chief Scientific Officer
Transactions
  • Award

    Stock Option

    2018-12-10+64,00064,000 total
    Exercise: $5.51Exp: 2028-12-10Common Stock (64,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option will vest over a period of four years, with 1/48th of the shares subject to the option vesting monthly.

Issuer

Menlo Therapeutics Inc.

CIK 0001566044

Entity typeother

Related Parties

1
  • filerCIK 0001727717

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 6:43 PM ET
Size
5.3 KB